Followers | 42 |
Posts | 950 |
Boards Moderated | 0 |
Alias Born | 02/02/2021 |

Tuesday, April 29, 2025 3:30:27 PM
-If clock started at 1/24/24 Validation, then 462 total days have passed.
-If clock started at 3/7/24 Confirmation of Validation, then 419 total days have passed.
How many of these total days could have been clock-off days, and therefore not counted against the MHRA?
https://www.gov.uk/guidance/national-assessment-procedure-for-medicines indicates that 270 (=180+90) days are available as clock-off days (plus an additional 270 clock-off days available to be granted by MHRA under exceptional circumstances)(see quote from webpage below).
So,
-If clock started at 1/24/24 Validation, then 462 total days have passed. If 270 of these days were taken as clock-off days, then there were only 192 clock-on days as of today.
-If clock started at 3/7/24 Confirmation of Validation, then 419 total days have passed. If 270 of these days were taken as clock-off days, then there were only 149 clock-on days as of today.
Assuming that NW took all of the clock-off days available, then as of March 31st (29 days ago), NW's MAA was still under 210 clock-on days and therefore could NOT be considered a backlogged application on March 31st according to MHRAs own metrics. (And therefore was not one of the backlogged MAAs that were referenced in the 3/18/25 MHRA meeting video)
see https://www.gov.uk/guidance/national-assessment-procedure-for-medicines states:
2.3 Initial assessment phase until Day 90
...
By Day 90 (90 calendar days after the start of the procedure) we will send you the first request for information (RFI) and switch off the clock.
2.4 Responses assessment phase until Day 150
You must respond to all questions raised in the first RFI within 6 months,.... In exceptional cases, we may agree to extend the clock-stop period beyond 6 months.
If we identify minor outstanding issues, we will send you a second RFI letter by Day 150 (see section 2.5).
...
We will stop the clock when we send out a second RFI or CHM letter.
2.5 Final assessment phase after second RFI
....You must submit your complete response to the second RFI within 3 months.... In exceptional cases, we may agree to extend the clock-stop period beyond 3 months.
Recent NWBO News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
- Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments • AllPennyStocks.com • 01/13/2025 01:56:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 10:07:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:29:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM